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Abstract 
Solitary rectal ulcer syndrome (SRUS) is often resistant to medical and surgical treatment. This 
study assessed the effect of biofeedback in decreasing the symptoms and the healing of 
endoscopic signs in SRUS patients. Before starting the treatment, endoscopy and colorectal 
manometry was performed to evaluate dyssynergic defecation. Patients were followed every 
four weeks, and during each visit their response to treatment was evaluated regarding to 
manometry pattern. After at least 50% improvement in manometry parameters, recipients 
underwent rectosigmoidoscopy. Endoscopic response to biofeedback treatment and clinical 
symptoms were investigated. Duration of symptoms was 43.11±36.42 months in responder and 
63.9 ± 45.74 months in non-responder group (P=0.22). There were more ulcers in non-
responder group than responder group (1.50 ±0.71 versus 1.33±- 0.71 before and   1.30 ± 0.95  
versus 0.67 ±0.50 after biofeedback), although the difference was not significant (P=0.604, 
0.10 respectively). The most prevalent symptoms were constipation (79%),  rectal bleeding 
(68%) and anorectal pain (53%). The most notable improvement in symptoms after 
biofeedback occured in abdominal pain and incomplete evacuation, and the least was seen in 
mucosal discharge and toilet waiting as shown in the bar chart. Endoscopic cure was observed 
in 4 of 10 patients of the non-responder group while 8 patients in responder group experienced 
endoscopic improvement. It seems that biofeedback has significant effect for pathophysiologic 
symptoms such as incomplete evacuation and obstructive defecation. Improvement of clinical 
symptoms does not mean endoscopic cure; so to demonstrate remission the patients have to go 
under rectosigmoidoscopy. 
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 The solitary rectal ulcer syndrome (SRUS) is a benign 
chronic disorder in young adults.1 SRUS is 
characterized by a combination of symptoms, clinical 
findings and histological abnormalities. Ulcers are only 
found in 40% of the patients; 20% of the patients have a 
solitary ulcer, and the rest of the lesions vary in shape 
and size, from hyperemic mucosa to broad-based 
polypoid. Men and women are affected equally, with a 
small predominance in women. SRUS has also been 
described in children and in the geriatric population. 
The pathogenesis of the solitary rectal ulcer (SRU) has 
not been yet clearly identified. As previous studies have 
shown, there is a reduction of hindgut mucosal blood 
flow in patients with functional constipation that can be 
increased with successful biofeedback therapy.2 SRU is 
uncommon and its treatment is difficult.3 For treating 
SRU, a wide range of therapeutic interventions from 
behavioral modification to surgery have been proposed. 
Generally there are two categories of treatment: surgical 
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and nonsurgical.4 Surgical modalities were reported to 
be effective for patients whose bleeding was so severe 
that made it necessary to transfuse them 10 pints of 
blood in a month.5 They are also effective for treating 
rectal prolapse (either with or without resection of the 
lesion)6 and those who are resistant to conservative 
therapies.7 There is no proven benefit for conservative 
treatments like fiber supplementation, laxatives, and 
attempted reduction of straining.8 While no history of 
straining has been found in some patients, a behavioral 
disorder seems to be present in others, which is 
characterized by excessive straining.  The good results 
achieved by behavioral therapies for defecation 
disorders made us to investigate the probable benefits of 
biofeedback retraining for SRU patients.9 There are only 
a few therapeutic control trials, none of them has led to 
a definitive treatment.10 Some previous studies have 
used biofeedback and behavioral approaches as the first 
line of treatment.11 This approach has led to about 54-
75% improvement of symptoms and sigmoidoscopic 
resolution of ulcer in 30% of cases.12-15 in another study, 
complete ulcer healing was observed in about 28% of 
patients with SRU and 33% of them were resistant to 
rectopexy.9 Regarding the facts that SRU has no definite 
treatment and the mean age of patients is 48 years old 
and it can disturb one’s diurnal function chronically and 
it causes absence of work, this treatment seems to be 
cost effective. The latest studies in this field have just 
investigated the symptoms of patients after biofeedback 
therapy, so this study aimed to evaluate both clinical 
symptoms and endoscopic signs during the treatment 
period to find out a staging and scoring for this 
therapeutic approach.15 
Materials and Methods 
In this prospective study, 19 patients who suffered with 
gastroenterology and liver diseases with diagnosis of 
SRU were referred to the Motility Department of 
Taleghani Hospital, Tehran, Iran from June 2013 to July 
2014.  These patients, evaluated for dyssynergic 
defecation, had been analyzed by endoscopy and 
pathology. A questionnaire on the symptoms and 
biofeedback therapy complaints, i.e., bowel frequency, 
increased time spent on toilet, straining, rectal blood 
loss, rectal mucus loss, need to anal digitation, sensation 
of incomplete emptying, abdominal pain, constipation, 
diarrhea, obstructive defecation and tenesmus was filled 
out for all patients by a trained nurse. Inclusion criteria 
included having bowel frequency, increased time spent 
on toilet, straining, rectal blood loss, rectal mucus loss, 
need to anal digitation, sensation of incomplete 
emptying, abdominal pain, constipation, diarrhea, 
obstructive defecation and tenesmus, who were 
diagnosed having SRU after confirmation by 
colonoscopy and rectal pathology and showed evidence 
of dyssynergic defecation in rectal manometry. They 
had no other problem in colonoscopy. Patients who 
candidate for anal surgery, having history of psychiatric 
disorders [Hospital Anxiety & Depression Scaling 
(HADS) scores11 or more], haemorrhoid grade 3 or 4, 
under medical treatment, constipation, acute or chronic 
anal fissure, overt rectal prolapse (by taking 
photographs with their cellphones), no response to 
biofeedback after 12 sessions based on manometry 
parameters, were excluded from the study. All patients 
after medical examination by a physician were 
submitted to routine blood and stool tests (microscopy 
and culture) for infections. 
Demographic and clinical data included age, sex, 
pharmacological treatment, clinical presentation, 
constipation scoring system form,16,17, ROME3 and 
SRUS symptoms (table1), duration of symptoms, 
HADS.18 The CSS consists of seven items that are 
scored using a five-point scoring system that ranges 
Table 1. Comparison based on the response to biofeedback. 
 Responder Non-Responder p-value 
Male gender 5 4 0.509 
Age(yr) 30.67 ±13.59 32.6 ±13.97 0.54 
Duration(m) 43.11 ±36.42 63.9 ± 45.74 0.22 
Number Of Ulcers before 1.33 ±0.71 1.50 ± 0.71 0.604 
Number of Ulcers after 0.67 ± 0.50 1.30 ±095 0.1 
Type of ulcers before   0.672 
Endoscopic Improvement   0.027 
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from 0 (none of the time) to 4 (all of the time) and one 
item that is rated on a 0–2 scale. The range of total score 
is from 0 (normal) to 30 (severe constipation). A cutoff 
score of 15 suggests constipation.16 Before starting 
therapeutic interventions, endoscopy and colorectal 
manometry (with eight channel high resolution 
manometry device from MMS company) was performed 
(by an expert gastroenterologist) to confirm dyssynergic 
defecation. The number of lesions, their type and 
location were recorded during endoscopy. The criteria 
investigated via manometry included: maximum 
squeeze pressure, sustained squeezing pressure and push 
maneuver. Definition of dyssynergic defecation was 
based on manometry: if 2/3 of manometric criteria were 
present, the diagnosis was confirmed. The patients filled 
consent forms after a complete description of the 
methodology. Management began with instructing all 
the patients by a resident of internal medicine. Patients 
were strongly advised to maintain regular bowel habits, 
and to avoid excessive straining during bowel 
evacuation. They were also asked to desist from doing 
manual evacuation. Patients then were treated with 
biofeedback. Biofeedback is a process, which allows an 
individual to learn how to alter his body’s physiological 
activity in order to improve health and performance. 
Biofeedback (verbal, visual) was done by a trained 
person. The visual biofeedback was provided by 
watching changes in pressure activity on the computer 
monitor. During biofeedback training sessions the 
patients were asked to lie down in right lateral position 
while being covered with a sheet. Initially the patients 
were ordered to relax and then to squeeze or strain 
gently for 10 seconds and repeat this process for many 
times to observe the changes. During biofeedback 
sessions we trained the patients to perform pelvic 
exercises and modifying their defecation habits via 
verbal instructions. Each biofeedback session lasted 
approximately 30-45 minutes. Patients were followed 
every 4 weeks and during each visit their response to 
treatment was measured via manometry. Response to 
biofeedback was defined as an improvement of at least 
50% in manometric criteria. After detecting a response 
to biofeedback, clinical symptoms (CSS and SRU 
symptoms) and endoscopic response were investigated. 
Patients who did not respond to biofeedback after a 
maximum of 12 sessions were excluded from the study. 
Response to treatment was categorized into one of four 
groups: major improvement (at least 80% reduction in 
symptoms), fair improvement (symptoms decreased 
more than 50%), mild improvement (symptoms 
decreased less than 50%), and none (less than 30% 
symptom reduction). Then the statistical analysis was 
performed separately in one of the two groups: 
responder group (with major or fair improvement) and 
non-responder group (with mild or no improvement). 
Endoscopic improvement was defined as going one 
stage back (changing from ulcer to polyp or from 
ulcer/polyp to erythema) and/or at least 50% reduction 
in size of the lesion. Endoscopic response was defined 
into two groups: improved group included one stage 
back (changing ulcer to polyp or ulcer/polyp to 
erythema) or decrease at least 50% in size of lesion. 
Unimproved group included otherwise conditions. 
Statistical analysis 
Test of normality for distribution of variables was 
performed using the Kolmogorov–Smirnov test. 
Qualitative variables were analysed by chi-square test 
and quantitative variables with a student t- test. Data are 
expressed as mean ± SD. Mann-Whitney u test was used 
to compare differences between both groups. We used 
default selection criteria of SPSS 19.0 for Windows 
(SPSS, Chicago, IL). 
Results and Discussion 
In this study were enrolled 19 patients from a total of 48 
SRU patients (mean age was 31.68 ± 13.44 years). 
Average number of biofeedback sessions was 6.9 (5 to 
10). Patients with at least a 50% improvement in the 
manometric parameters were more than 80% of enrolled 
 
 
Fig 1: Prevalence of symptoms 
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subjects. In 50% of cases decrease in size of the lesion 
has been observed. Demographic characteristics of the 
study population is presented in table 1. After 
completion of biofeedback sessions, patients were 
divided into two groups (responder and non-responder) 
based on clinical improvement (CSS form, SRU 
symptoms that were reported by the patients). 
Improvement in symptoms consider as; major (> 80%) 
and fair (50% to 80%) improvement in patients’ 
symptoms as “responder” and mild (30% to50%) or no 
improvement (<30%) as “non-responder”. There is no 
significant difference in sex and age distribution (p = 
0.5). Duration of symptoms was 43.11±36.42 months in 
responder and 63.9 ± 45.74 months in non-responder 
group (P=0.22). There were more ulcers in non-
responder group than responder group (1.50 ±0.71 
versus 1.33±- 0.71 before and 1.30 ± 0.95    versus 0.67 
±0.50 after biofeedback), although the difference was 
not significant (P=0.604, 0.10 respectively) (table 1). 
Our results showed three types of solitary rectal ulcers, 
defined erythema, polyp, and ulcer. Before biofeedback 
therapy 6 patients had polyp and 13 had ulcer. Two of 
the polyps changed to erythema, one of them had no 
change and others healed. Figure 1 shows that the most 
prevalent symptoms were constipation (79%), rectal 
bleeding (68%) and anorectal pain (53%). Less common 
symptoms included incontinency, diarrhea and 
increased bowel motion. The most notable improvement 
in symptoms after biofeedback occured in abdominal 
pain and incomplete evacuation, and the least was seen 
in mucosal discharge and toilet waiting as shown in the 
bar chart (Figure 2). The average number of 
biofeedback sessions was 6.5 times in responder group 
and 7.1 times in the non-responder group. There was 
any significant difference between the two groups (p-
value = 0.38). Significant difference between responder 
and non-responder groups was endoscopic improvement 
as shown in the cross tabulation below. Endoscopic 
improvement was observed in 4 of 10 patients of the 
non-responder group while in 8 of 9 patients in 
responder group, which implied a significant difference 
between them (p = 0.027). The data of this study show 
that biofeedback is more effective in polypoid type 
lesion than in ulcerative type. Most of the previous 
studies have investigated only clinical improvement 
without endoscopic evaluation. In our study there was 
significant difference in endoscopic findings between 
responder group and non-responder group (p-value = 
0.027) but no significant difference found in clinical 
responses between the two groups in regard to the 
duration of symptoms, type and number of ulcers and 
age; although in non-responder group the number of 
ulcers and duration of symptoms was greater and age of 
patients was older. It means that real SRUS 
improvement resulted from endoscopic improvement 
and not merely a consequence of symptom therapy. 
SRUS is an uncommon, benign and chronic disorder 
often diagnosed in young adults and middle-aged, and is 
usually related to straining or abnormal defecation. 
Several treatments have been suggested for this 
disorder, including topical medications, behavioral 
modification in combination with fiber supplements and 
biofeedback, and surgery. Patient education is required 
for good management of this disorder along with a 
stepwise conservative approach individualized for each 
patient.19  
Patients who only suffer from mild symptoms without 
any rectal prolapse are considered appropriate for 
conservative management in which stool bulking agents 
are used in conjunction with biofeedback therapy for 
retraining the patients’ bowel habits. Tjandra et al 
claimed that preventing the paradoxical contraction of 
puborectalis muscle and managing constipation are the 
main goals of therapy.20 Whereas, Halligan showed in 
 
 
Fig 2. Improvement in symptoms after biofeedback 
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patients suffering from rectal prolapse, conservative 
management alone is rarely effective and hence surgery 
(usually abdominal rectopexy) may become 
necessary.21. Palsson and Jorge in separated studies 
reported the efficacy of biofeedback therapy in 
managing functional anorectal disorders like functional 
constipation and functional fecal incontinence.22, 23. 
Previous studies have confirmed that for many SRUS 
patients gut directed biofeedback could be an effective 
behavioral treatment.12, 24,25. In those studies about 75% 
of patients reported subjective improvement.24. Vaizey 
et al. presenting endoscopic evaluation of these patients 
showed that the rectal ulcer had healed in 31% of them 
after biofeedback therapy.25 Behavioral treatment could 
change the bowel function and its blood flow by several 
mechanisms. Improvement of mucosal microcirculation 
and bowel transit may result from changes in autonomic 
innervations of the bowels via some cerebral 
mechanisms. Previous studies have shown that extrinsic 
autonomic innervations to the bowels exhibit changes in 
their activity level which are correlated to psychological 
factors.26 The increased blood flow to the rectal mucosa 
may also be attributed to the improved psycho-social 
functioning as a consequence of behavioral treatment. 
Another possible mechanism for enhanced blood flow 
may be the improved rectal motor function.27 
Furthermore, during the last few years multiple studies 
have been published similar to those described above.28-
30 A behavioral approach seems to be of therapeutic 
benefit for some SRU patients. It often makes them feel 
subjectively better, improves many symptoms 
associated with bowel function, and allows some 
patients to go back to work again. Since in some 
patients SRUS may be related to chronic straining, it 
seems rational to use retraining toileting behavior as a 
treatment strategy. Biofeedback therapy does not solely 
include retraining co-ordination of pelvic floor muscles. 
In this approach patients are also taught the appropriate 
posture and correct use the abdominal muscles during 
defecation, and they are made to follow a discipline 
about the amount of time being spent in the toilet, 
number of visits to the toilet, self digitation, and using 
laxatives. It also brings them psychological support. 
Therefore the term “biofeedback” in this context entails 
a complex entity composed of several complementary 
parts such as behavioral conditioning, paying more 
attention to the defecatory process and likely other 
psychological factors.  
The most important limitation of this study was the 
study population. Another limitation was related to the 
last of follow-ups. This problem was resolved with 
calling back the participants and explaining the 
importance of follow-up visits in the treatment process, 
though ultimately some cases had to be excluded from 
the study. In conclusion, it seems that Biofeedback is 
more effective in polypoid type of lesion than in 
ulcerative type, though to reach conclusive results 
require a larger sample size. 
List of acronyms 
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